BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24808022)

  • 1. PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.
    Nelson MD; Rader F; Tang X; Tavyev J; Nelson SF; Miceli MC; Elashoff RM; Sweeney HL; Victor RG
    Neurology; 2014 Jun; 82(23):2085-91. PubMed ID: 24808022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
    Martin EA; Barresi R; Byrne BJ; Tsimerinov EI; Scott BL; Walker AE; Gurudevan SV; Anene F; Elashoff RM; Thomas GD; Victor RG
    Sci Transl Med; 2012 Nov; 4(162):162ra155. PubMed ID: 23197572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
    Adamo CM; Dai DF; Percival JM; Minami E; Willis MS; Patrucco E; Froehner SC; Beavo JA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19079-83. PubMed ID: 20956307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats.
    Küçük A; Yucel M; Erkasap N; Tosun M; Koken T; Ozkurt M; Erkasap S
    Mol Biol Rep; 2012 Oct; 39(10):9775-82. PubMed ID: 22736111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
    González-Corrochano R; La Fuente J; Cuevas P; Fernández A; Chen M; Sáenz de Tejada I; Angulo J
    Br J Pharmacol; 2013 May; 169(2):449-61. PubMed ID: 23441682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PDE5 inhibition on the modulation of sympathetic α-adrenergic vasoconstriction in contracting skeletal muscle of young and older recreationally active humans.
    Nyberg M; Piil P; Egelund J; Sprague RS; Mortensen SP; Hellsten Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1867-75. PubMed ID: 26432842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacodynamic interaction of silodosin, a highly selective alpha1a-adrenoceptor antagonist, with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men.
    MacDiarmid SA; Hill LA; Volinn W; Hoel G
    Urology; 2010 Mar; 75(3):520-5. PubMed ID: 20080287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular blood flow in Duchenne and Becker Muscular Dystrophy: Quantitative power Doppler sonography relates to disease severity.
    Dietz AR; Connolly A; Dori A; Zaidman CM
    Clin Neurophysiol; 2020 Jan; 131(1):1-5. PubMed ID: 31751835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophy.
    Nelson MD; Rosenberry R; Barresi R; Tsimerinov EI; Rader F; Tang X; Mason O; Schwartz A; Stabler T; Shidban S; Mobaligh N; Hogan S; Elashoff R; Allen JD; Victor RG
    J Physiol; 2015 Dec; 593(23):5183-200. PubMed ID: 26437761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
    Martínez-Salamanca JI; La Fuente JM; Cardoso J; Fernández A; Cuevas P; Wright HM; Angulo J
    J Sex Med; 2014 May; 11(5):1182-92. PubMed ID: 24877179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.
    Weiss J; Theile D; Spalwisz A; Burhenne J; Riedel KD; Haefeli WE
    Biochem Pharmacol; 2013 Jan; 85(2):265-73. PubMed ID: 23219525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in vitro.
    Aversa A; Caprio M; Antelmi A; Armani A; Brama M; Greco EA; Francomano D; Calanchini M; Spera G; Di Luigi L; Rosano GM; Lenzi A; Migliaccio S; Fabbri A
    J Sex Med; 2011 Mar; 8(3):696-704. PubMed ID: 21176111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy.
    Witting N; Kruuse C; Nyhuus B; Prahm KP; Citirak G; Lundgaard SJ; von Huth S; Vejlstrup N; Lindberg U; Krag TO; Vissing J
    Ann Neurol; 2014 Oct; 76(4):550-7. PubMed ID: 25042931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Yuan J; Zhang R; Yang Z; Lee J; Liu Y; Tian J; Qin X; Ren Z; Ding H; Chen Q; Mao C; Tang J
    Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.
    Batra A; Vohra RS; Chrzanowski SM; Hammers DW; Lott DJ; Vandenborne K; Walter GA; Forbes SC
    J Appl Physiol (1985); 2019 Jun; 126(6):1737-1745. PubMed ID: 30946638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.